EQRx, Inc.

CM Life Sciences III Acquisition Corp, trading under the ticker CMLT, is a blank-check company sponsored by CM Life Sciences and focused on the healthcare and biopharmaceutical sector. The SPAC completed its IPO in 2021 and filed an 8-K with the SEC on August 6, 2021, under accession number 0001213900-21-040657, in connection with its proposed business combination with EQRx, Inc., a pharmaceutical company focused on developing and commercializing innovative medicines at lower prices. The transaction represented a notable deal in the life sciences SPAC space during a period of elevated activity in healthcare-focused blank-check vehicles. Sign up for full data, filings, and deal tracking on SpacDesk.